Dr. Erik Årstad
Årstad, Ph.D. is
Senior Lecturer in Radiochemistry at the University College London.
Erik coauthored Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide, [18F]Fluoromethyl-[1,2-2H4]-choline: A novel radiotracer for imaging choline metabolism in tumors by positron emission tomography, Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy — a [123I]CNS-1261 SPET study, ROMPgel-supported tris(triphenylphosphine)rhodium(I) chloride: a selective hydrogenation catalyst for parallel synthesis, and Towards NR2B receptor selective imaging agents for PET — synthesis and evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidine. Read the full list of his publications!
Erik earned his Ph.D. in Radiochemistry at the University of Oslo, Norway in 2001. He holds patent Selective radiolabeling of biomolecules and patent applications Radiofluorination and Radiolabelling methods.
Read Biological fate of nanoparticles in the body. Read his ResearchGate profile.